...
首页> 外文期刊>Molecular biology reports >Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population
【24h】

Six lipoprotein lipase gene polymorphisms, lipid profile and coronary stenosis in a Tunisian population

机译:突尼斯人群中六种脂蛋白脂肪酶基因多态性,脂质谱和冠状动脉狭窄

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Lipoprotein lipase (LPL) is the rate-limiting enzyme in the hydrolysis of triglyceride-rich lipoprotein particles (Chylomicrons and very-low-density lipoprotein). LPL polymorphisms’ effects on lipids and coronary artery disease are controversial among studies and populations. Our aim was to study the association between six polymorphisms, haplotypes and significant coronary stenosis (SCS), disease severity and lipid parameters in Tunisian patients. LPL PvuII, 93 T/G, 188 G/E, HindIII, N291S and D9N polymorphisms were analyzed in 316 patients who underwent coronary angiography. Assessment of coronary angiograms identified SCS as the presence of stenosis >50 % in at least one major coronary artery. The stenosis severity was determined by using Gensini score and vessels number. A significant association of SCS with TT of the HindIII polymorphism was showed (odds ratio (OR): 2.84, 95 % CI, 1.19–7.40, p = 0.017) and TG (OR: 1.77, 95 % CI, 1.99–2.82, p = 0.033). The mutated HindIII genotype was significantly associated with increased TG and ApoB/ApoA-I ratio and with decreased HDL-C. Haplotype analysis showed that OR of SCS associated with the CTGTAG haplotype was 2.12 (95 % CI 1.05–4.25, p = 0.032) and with CGGGAA was 0.71 (95 % CI 0.26–1.95, p = 0.022) compared to the CTGTAA. Significant difference in Gensini score was observed among HindIII genotype and haplotypes. A significant association between the mutated genotype of HindIII polymorphism and decreased HDL-C level and increased ApoB/ApoA-I ratio and TG level was showed. Our results suggest that HindIII and D9N polymorphisms and CTGTAG haplotype seem to be considered as marker of predisposition to coronary stenosis. In another hand, HindIII and haplotypes were related to stenosis severity.
机译:脂蛋白脂肪酶(LPL)是富含甘油三酸酯的脂蛋白颗粒(超微粒子和极低密度脂蛋白)水解中的限速酶。 LPL多态性对脂质和冠状动脉疾病的影响在研究和人群中引起争议。我们的目的是研究突尼斯患者的六种多态性,单倍型与明显的冠状动脉狭窄(SCS),疾病严重程度和血脂参数之间的关系。分析了316例接受冠状动脉造影的患者的LPL PvuII,93 T / G,188 G / E,HindIII,N291S和D9N多态性。评估冠状动脉造影照片可确定SCS为至少一根主要冠状动脉中狭窄> 50%。狭窄严重程度通过Gensini评分和血管数目确定。结果表明,SCS与HindIII多态性的TT显着相关(优势比(OR):2.84,95%CI,1.19–7.40,p = 0.017)和TG(OR:1.77,95%CI,1.99–2.82,p = 0.033)。突变的HindIII基因型与TG和ApoB / ApoA-I比例升高以及HDL-C降低显着相关。单倍型分析显示,与CTGTAA相比,与CTGTAG单倍型相关的SCS的OR为2.12(95%CI 1.05–4.25,p = 0.032),与CGGGAA关联的为0.71(95%CI 0.26-1.95,p = 0.022)。在HindIII基因型和单倍型之间观察到Gensini得分的显着差异。结果显示,HindIII基因多态性的突变基因型与HDL-C水平降低,ApoB / ApoA-I比值和TG水平升高之间存在显着相关性。我们的结果表明,HindIII和D9N多态性和CTGTAG单倍型似乎被认为是冠状动脉狭窄易感性的标志。另一方面,HindIII和单倍型与狭窄严重程度有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号